Increased tumor-infiltrating CD4+ T-cell counts and an increased CD4+:CD8+ T-cell ratio were significantly correlated with improved patient response to BCG in bladder cancer patients' tumor samples10. The gene discussed is CD8A; the disease is urinary bladder carcinoma.